231 results
Page 4 of 12
6-K
EX-99
w2c8qpuaw6b9
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
rb6sggcqqloz nw9s7
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
ck9umrm8 hshcj9mu
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
EX-23.1
y5sj dbo9r
31 Dec 20
Shelf registration (foreign)
4:37pm
F-3
urfqq85qeifv8awp
31 Dec 20
Shelf registration (foreign)
4:37pm
F-3
EX-5.1
ek8l7qws oupg
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
k0remm9b2s2
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
k22vle5
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
424B5
5m6 ym7k3j065b
13 Nov 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-1
d0bpa030r00z
30 Oct 20
BioLineRx Announces Positive Results from Interim Analysis of
7:09am
6-K
EX-10.1
5nyn pszvy4f
25 Sep 20
Current report (foreign)
4:33pm
424B5
t57c 3clb
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
3yh e7tli
24 Sep 20
Current report (foreign)
4:30pm
6-K
EX-99
4zpk18cbkuumj
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-99
jt3axm70owfvyz8 6d
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-99
6lq0i ogss
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
POS AM
vcmb5ubal
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
POS AM
EX-23.1
41irt 7gmx0ldjo
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
424B3
1dzyp zqojnc8n
2 Jul 20
Prospectus supplement
4:28pm
F-1
EX-23.1
modqn70 1qt6w59kzr
26 Jun 20
Registration statement (foreign)
4:30pm